Searched for
EGFR
Creatinine too high? What it reveals about kidney healthBreaking down what high creatinine means in plain language. Understand how it links to kidney function, when it signals a problem, common c...- New study reveals the underrated proteins diabetics should load up on for better blood sugarA new study suggests that individuals with type 2 diabetes can lower their risk of kidney disease by increasing their intake of leucine and...
- Chronic kidney disease explained: 5 stages, symptoms and prevention tips you needChronic kidney disease (CKD) is a slow health problem that affects how well your kidneys clean your blood. It has five stages that range fr...
- Too much or too little sleep? Apollo doctor uncovers surprising kidney and diabetes warningA recent study involving over 1,300 adults with diabetes revealed a U-shaped pattern in sleep's impact on kidney health. Both insufficient ...
- AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug DurvalumabAstraZeneca Pharma Share Price: The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple ...
- Boehringer's Jardiance now gets CDSCO nod for chronic kidney diseaseThe Central Drugs Standard Control Organisation of India has approved Jardiance, a 10mg dosage form of empagliflozin, for the treatment of ...
- Sun Pharma inks pact with Bayer to sell drug for chronic kidney diseaseSun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights...
- Cancer therapy firm Bicara raises $165 millionBicara, founded in 2020 and based in Cambridge, Massachusetts, is a clinical-stage biotechnology company currently developing dual-action b...
- Tobacco leaves have a compound to fight several types of cancer: StudyResearchers from various countries, including an alumnus of Allahabad University, have discovered a compound derived from tobacco leaves th...
- Miracle pill can keep lung cancer at bay: ReportThe treatment developed by the pharmaceutical group AstraZeneca is called osimertinib and is marketed under the name Tagrisso.
- How to check kidney's health? Here are two simple testsYou may be losing kidney functions for many years without significant symptoms. People often get to know about their condition only when th...
- New AI system may be able to identify lung cancer typeThe AI tool was also able to determine whether abnormal versions of 6 genes linked to lung cancer were present in cells.
- Good cancer drug data helps AstraZeneca in Pfizer fightBritain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
- Biocon rolls out its first biologic drug for the treatment of psoriasisCalled ALZUMAb, it took 10 years in the making and "is recognition of innovation done by research and development wing of Biocon," said Kir...
- Biocon seeking partners to develop, market psoriasis drugBiotechnology major Biocon today said it is looking for partners to develop and market its novel biologic drug Itolizumab
- Biocon to launch psoriasis drug novel biologic in JulyThe company had received marketing authorisation for Itolizumab from the Drugs Controller General of India (DCGI) in January, 2013.
- Biocon launches stand alone cardiology divisionBiotech major, Biocon, has decided to split its cardio-diabetes group by launching a stand alone cardiology division.
- Biocon picks up 70% in German pharma co AxiCorp for e30 mnThe deal will enable the Bangalore-based player to market its injectible insulin, generics, biosimilars and biologics in Europe.
- Biocon may launch new anti-arthritis drugLeading biotech company, Biocon Limited on Monday said it expects to launch a new anti-arthritis drug in the next 3-4 years in the market, ...
- World's first anti-EGFR cancer antibody launchedBiotechnology behemoth Biocon has launched BIOMAb-EGFR, a therapeutic monoclonal antibody-based drug for treating solid tumours of epitheli...
Load More
